Cargando…
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study
SIMPLE SUMMARY: The choice of first-line regimen represents a critical step in the therapeutic road for patients with metastatic colorectal cancer (mCRC) because the response to first-line treatment is the primary determinant of outcomes. The extended characterization of RAS and BRAF mutational stat...
Autores principales: | Procaccio, Letizia, Bergamo, Francesca, Daniel, Francesca, Rasola, Cosimo, Munari, Giada, Biason, Paola, Crucitta, Stefania, Barsotti, Giulia, Zanella, Giulia, Angerilli, Valentina, Magro, Cristina, Paccagnella, Silvia, Di Antonio, Veronica, Loupakis, Fotios, Danesi, Romano, Zagonel, Vittorina, Del Re, Marzia, Lonardi, Sara, Fassan, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533756/ https://www.ncbi.nlm.nih.gov/pubmed/34680277 http://dx.doi.org/10.3390/cancers13205128 |
Ejemplares similares
-
An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer
por: Prete, Alessandra Anna, et al.
Publicado: (2022) -
Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches
por: Ceccon, Carlotta, et al.
Publicado: (2022) -
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
por: Loupakis, Fotios, et al.
Publicado: (2019) -
Immunotherapy in Gastrointestinal Cancers
por: Procaccio, Letizia, et al.
Publicado: (2017) -
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases
por: Loupakis, Fotios, et al.
Publicado: (2021)